BG104009A - Quinoline-4-carboxamide derivatives as neuroquinine-2 and neuroquinine-3 receptor antagonists - Google Patents
Quinoline-4-carboxamide derivatives as neuroquinine-2 and neuroquinine-3 receptor antagonistsInfo
- Publication number
- BG104009A BG104009A BG104009A BG10400999A BG104009A BG 104009 A BG104009 A BG 104009A BG 104009 A BG104009 A BG 104009A BG 10400999 A BG10400999 A BG 10400999A BG 104009 A BG104009 A BG 104009A
- Authority
- BG
- Bulgaria
- Prior art keywords
- alkyl
- optionally substituted
- alkylamino
- aryl
- group
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
- C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
- C07D251/12—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D251/26—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hetero atoms directly attached to ring carbon atoms
- C07D251/40—Nitrogen atoms
- C07D251/48—Two nitrogen atoms
- C07D251/52—Two nitrogen atoms with an oxygen or sulfur atom attached to the third ring carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9710750.2A GB9710750D0 (en) | 1997-05-23 | 1997-05-23 | Novel compounds |
IT002354 IT1295358B1 (it) | 1997-10-17 | 1997-10-17 | Derivati chinolinici procedimento per la loro preparazione e uso come antagonisti del recettore nk3 |
ITMI972775 IT1296976B1 (it) | 1997-12-16 | 1997-12-16 | Derivati chinolinici procedimento per la loro preparazione e uso come antagonisti del recettore nk3 |
PCT/EP1998/003014 WO1998052942A1 (en) | 1997-05-23 | 1998-05-18 | Quinoline-4-carboxamide derivatives as nk-2 and nk-3 receptor antagonists |
Publications (1)
Publication Number | Publication Date |
---|---|
BG104009A true BG104009A (en) | 2000-07-31 |
Family
ID=27268859
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BG104009A BG104009A (en) | 1997-05-23 | 1999-12-14 | Quinoline-4-carboxamide derivatives as neuroquinine-2 and neuroquinine-3 receptor antagonists |
Country Status (26)
Country | Link |
---|---|
EP (1) | EP0983262B1 (de) |
JP (1) | JP2002500645A (de) |
CN (1) | CN1264378A (de) |
AP (1) | AP9901695A0 (de) |
AR (1) | AR012732A1 (de) |
AT (1) | ATE244711T1 (de) |
AU (1) | AU8209898A (de) |
BG (1) | BG104009A (de) |
BR (1) | BR9809652A (de) |
CA (1) | CA2291111A1 (de) |
CO (1) | CO4950515A1 (de) |
DE (1) | DE69816290T2 (de) |
DZ (1) | DZ2498A1 (de) |
EA (1) | EA199901062A1 (de) |
ES (1) | ES2201509T3 (de) |
HU (1) | HUP0002300A3 (de) |
ID (1) | ID22876A (de) |
IL (1) | IL133036A0 (de) |
MA (1) | MA26501A1 (de) |
NO (1) | NO995711L (de) |
OA (1) | OA11515A (de) |
PE (1) | PE75199A1 (de) |
PL (1) | PL336942A1 (de) |
SK (1) | SK159299A3 (de) |
TR (1) | TR199902883T2 (de) |
WO (1) | WO1998052942A1 (de) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9825554D0 (en) | 1998-11-20 | 1999-01-13 | Smithkline Beecham Spa | Novel Compounds |
MXPA01005095A (es) * | 1998-11-20 | 2002-04-24 | Smithkline Beecham Spa | Derivados de quinolin-4-carboxamida como antagonistas de receptor de neurocinina-3 y neurocinina-2. |
US6780875B2 (en) * | 1998-11-20 | 2004-08-24 | Smithkline Beecham S.P.A. | Quinoline-4-carboxamide derivatives as NK-3 and NK-2 receptor antagonists |
JP2002540203A (ja) | 1999-03-29 | 2002-11-26 | ニューロゲン コーポレイション | Nk−3および/またはgaba(a)受容体リガンドとしての4−置換キノリン誘導体 |
AU4802500A (en) | 1999-04-26 | 2000-11-10 | Neurogen Corporation | 2-aminoquinolinecarboxamides: neurokinin receptor ligands |
AU2001276556A1 (en) * | 2000-08-11 | 2002-02-25 | Smithkline Beecham P.L.C. | Novel pharmaceutical use of quinnoline derivatives |
EP1334089A1 (de) * | 2000-11-13 | 2003-08-13 | GlaxoSmithKline S.p.A. | Chinolinderivate als nk-3- und nk-2-antagonisten |
GB0028964D0 (en) * | 2000-11-28 | 2001-01-10 | Smithkline Beecham Spa | Novel compounds |
EP1351953A1 (de) * | 2000-11-28 | 2003-10-15 | GlaxoSmithKline S.p.A. | Chinolinderivate als nk-3-antagonisten |
US6540733B2 (en) | 2000-12-29 | 2003-04-01 | Corazon Technologies, Inc. | Proton generating catheters and methods for their use in enhancing fluid flow through a vascular site occupied by a calcified vascular occlusion |
EP1659120A1 (de) * | 2001-04-11 | 2006-05-24 | GlaxoSmithKline S.p.A. | 3-substituierte Chinolin-4-Carboxamidderivate als NK-3 und NK-2 Rezeptor Antagonisten |
GB0109122D0 (en) * | 2001-04-11 | 2001-05-30 | Smithkline Beecham Spa | Novel compounds |
MY134211A (en) * | 2001-05-18 | 2007-11-30 | Smithkline Beecham Corp | Novel use |
GB0425075D0 (en) * | 2004-11-12 | 2004-12-15 | Smithkline Beecham Corp | Novel compounds |
GB0425077D0 (en) * | 2004-11-12 | 2004-12-15 | Smithkline Beecham Corp | Novel compounds |
GB0425076D0 (en) * | 2004-11-12 | 2004-12-15 | Smithkline Beecham Corp | Novel compounds |
KR20080016591A (ko) * | 2005-06-03 | 2008-02-21 | 아스트라제네카 아베 | Nk3 길항제로서의 퀴놀린 유도체 |
GB0515580D0 (en) | 2005-07-29 | 2005-09-07 | Merck Sharp & Dohme | Therapeutic compounds |
AR057130A1 (es) | 2005-09-21 | 2007-11-14 | Astrazeneca Ab | Quinolinas de alquilsulfoxido y una composicion farmaceutica |
DE202007017299U1 (de) * | 2007-12-12 | 2009-04-23 | Drebo Werkzeugfabrik Gmbh | Bohrer |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE246677T1 (de) * | 1994-05-27 | 2003-08-15 | Smithkline Beecham Farma | Chinolinderivate als tachykinin nk3 rezeptor antagonisten |
AR004735A1 (es) * | 1995-11-24 | 1999-03-10 | Smithkline Beecham Spa | Quinoleina 4-amido sustituida, un procedimiento para su preparacion, una composicion farmaceutica que los contiene y el uso de los mismos para lapreparacion de un medicamento. |
-
1998
- 1998-05-18 WO PCT/EP1998/003014 patent/WO1998052942A1/en not_active Application Discontinuation
- 1998-05-18 TR TR1999/02883T patent/TR199902883T2/xx unknown
- 1998-05-18 SK SK1592-99A patent/SK159299A3/sk unknown
- 1998-05-18 HU HU0002300A patent/HUP0002300A3/hu unknown
- 1998-05-18 PL PL98336942A patent/PL336942A1/xx unknown
- 1998-05-18 CA CA002291111A patent/CA2291111A1/en not_active Abandoned
- 1998-05-18 ES ES98932069T patent/ES2201509T3/es not_active Expired - Lifetime
- 1998-05-18 AP APAP/P/1999/001695A patent/AP9901695A0/en unknown
- 1998-05-18 AT AT98932069T patent/ATE244711T1/de not_active IP Right Cessation
- 1998-05-18 CN CN98807356A patent/CN1264378A/zh active Pending
- 1998-05-18 AU AU82098/98A patent/AU8209898A/en not_active Abandoned
- 1998-05-18 JP JP54996798A patent/JP2002500645A/ja not_active Ceased
- 1998-05-18 EP EP98932069A patent/EP0983262B1/de not_active Expired - Lifetime
- 1998-05-18 IL IL13303698A patent/IL133036A0/xx unknown
- 1998-05-18 DE DE69816290T patent/DE69816290T2/de not_active Expired - Fee Related
- 1998-05-18 BR BR9809652-4A patent/BR9809652A/pt not_active IP Right Cessation
- 1998-05-18 EA EA199901062A patent/EA199901062A1/ru unknown
- 1998-05-18 ID IDW991432A patent/ID22876A/id unknown
- 1998-05-19 DZ DZ980108A patent/DZ2498A1/xx active
- 1998-05-20 PE PE1998000398A patent/PE75199A1/es not_active Application Discontinuation
- 1998-05-21 AR ARP980102363A patent/AR012732A1/es not_active Application Discontinuation
- 1998-05-21 MA MA25086A patent/MA26501A1/fr unknown
- 1998-05-22 CO CO98029024A patent/CO4950515A1/es unknown
-
1999
- 1999-11-22 NO NO995711A patent/NO995711L/no not_active Application Discontinuation
- 1999-11-23 OA OA9900253A patent/OA11515A/en unknown
- 1999-12-14 BG BG104009A patent/BG104009A/xx unknown
Also Published As
Publication number | Publication date |
---|---|
CA2291111A1 (en) | 1998-11-26 |
CN1264378A (zh) | 2000-08-23 |
HUP0002300A2 (hu) | 2001-06-28 |
EP0983262A1 (de) | 2000-03-08 |
PE75199A1 (es) | 1999-10-22 |
OA11515A (en) | 2004-02-04 |
AR012732A1 (es) | 2000-11-08 |
BR9809652A (pt) | 2001-09-11 |
PL336942A1 (en) | 2000-07-17 |
EA199901062A1 (ru) | 2000-08-28 |
MA26501A1 (fr) | 2004-12-20 |
EP0983262B1 (de) | 2003-07-09 |
NO995711L (no) | 2000-01-19 |
WO1998052942A1 (en) | 1998-11-26 |
AU8209898A (en) | 1998-12-11 |
TR199902883T2 (xx) | 2000-05-22 |
DZ2498A1 (fr) | 2003-01-25 |
ID22876A (id) | 1999-12-16 |
NO995711D0 (no) | 1999-11-22 |
DE69816290T2 (de) | 2004-05-27 |
HUP0002300A3 (en) | 2002-01-28 |
ES2201509T3 (es) | 2004-03-16 |
JP2002500645A (ja) | 2002-01-08 |
DE69816290D1 (de) | 2003-08-14 |
SK159299A3 (en) | 2000-06-12 |
AP9901695A0 (en) | 1999-12-31 |
IL133036A0 (en) | 2001-03-19 |
ATE244711T1 (de) | 2003-07-15 |
CO4950515A1 (es) | 2000-09-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BG104009A (en) | Quinoline-4-carboxamide derivatives as neuroquinine-2 and neuroquinine-3 receptor antagonists | |
MX9804108A (es) | Derivados de quinolina-4-carboxamida, su preparacion y uso como antagonistas receptores de neuroquinina 3 (nk-3)- y neuroquinina 2 (kn-2). | |
AR004972A1 (es) | Compuesto quinolino 4-carboxamidas n-sustituidas, un procedimiento para su preparacion, el uso de los mismos para la fabricacion de un medicamento, una composicion farmaceutica y un antagonista nk-2/nk-3 combinado. | |
NO20004778L (no) | Amidderivater og nociceptin antagonister | |
BR9915475A (pt) | Derivados da quinolina-4-carboxamida comoantagonistas dos receptores de nk-3 e nk-2 | |
DE69710319D1 (de) | Para-substituierte phenylpropansäure derivate als integrin-antagonisten | |
DK1539700T3 (da) | 8-hydroxyquinolin-derivater | |
UA72917C2 (en) | Cyclic carbamates derivatives, pharmaceutical composition containing said derivatives of cyclic carbamates and active ingredients as modulators of the progesterone receptor | |
CA2238171A1 (en) | Quinoline derivatives as nk3 antagonists | |
EE9800062A (et) | 8-asabitsüklo[3.2.1.]okt-2-eeni derivaadid, nende valmistamine ja kasutamine | |
SE0101579D0 (sv) | New compounds | |
EA200400994A1 (ru) | Новые 1,2,3-замещенные производные индолизина, являющиеся ингибиторами факторов роста фибробластов, способ их получения и фармацевтические композиции, содержащие их | |
MY146599A (en) | New azetidine compounds | |
BG100883A (en) | Tropane-2-aldoxine derivatives as neurotransmitter reuptake inhibitors | |
HUP0302193A2 (hu) | 1,4-Diazabiciklo[3.2.2]nonán-benzoxazol,-benzotiazol és -benzimidazol-származékok, előállításuk és ezeket tartalmazó gyógyszerkészítmények | |
ATE469157T1 (de) | Tetrahydrofuroä3,4-düdioxolverbindungen und zusammensetzungen und verfahren zur inhibierung der trombozytenaggregation | |
DE69934514D1 (de) | Chinolinderivate als nk-2 und nk-3 rezeptor-liganden | |
HUP0004855A2 (hu) | Eljárás kinolinszármazékok előállítására és az eljárás intermedierjei | |
EA200301171A1 (ru) | Новые соединения трициклических дигидрохинолинов, способ их получения и фармацевтические композиции, содержащие их | |
YU34499A (sh) | Derivati 5-aroilnaftalena | |
AR035718A1 (es) | Derivados de quinolina, procedimientos para su preparacion, composiciones farmaceuticas que lo comprenden, y el uso de tales compuestos en la fabricacion de medicamentos | |
NZ323388A (en) | Quinoline-4-carboxamide derivatives, their preparation and their use as neurokinin 3 (NK-3) and neurokinin 2 (NK-2) receptor antagonists | |
BG106079A (en) | Cyclocarbamate derivatives as progesterone receptor modulators | |
BR9609548A (pt) | Composto heterocíclicos para o tratamento da dor método para induzir analgesia num mamífero e método para ativar um receptor opióide num mamífero | |
HUP0000768A2 (hu) | Szubsztituált benzo[1,4]dioxánok, eljárás előállításukra és ezeket tartalmazó gyógyszerkészítmények |